IPD vs RAD

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IPD

IMPEDIMED FPO [IPD]

48LOW

RAD

RADIOPHARM FPO [RAD]

40LOW

Score Breakdown

IPD RAD
Technical
57
55
Catalyst
55
53
Sentiment
50
50
Fundamental
95
76
Momentum
30
45
Risk Gate
27
37

Key Metrics

IPD Metric RAD
$22.0MMarket Cap$47.3M
6.9MAvg Volume (20d)4.5M
N/AShort Interest+0.0%
$0.05952-Week High$0.040
$0.00552-Week Low$0.017
+0.0%Daily Change+0.0%
$0.006Reference Price$0.020
-117.9%ROE-92.1%
-171.3%Profit Margin-286.2%

Active Signals

IPD Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (5 quarters)
●Low P/S ratio (1.5x)
●Strong revenue growth (+25%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week low (2% of range)

RAD Signals

●MACD momentum is picking up steam
●Above-average volume (1.5x) on a green day — buyers stepping up
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Low P/S ratio (2.9x)
●Strong revenue growth (+154%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare IPD and RAD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IPD vs REG →IPD vs RHY →LDX vs MVP →LDX vs NAN →LDX vs NTI →
IPD Full Analysis → RAD Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).